Skip to main content
Journal cover image

Poor T Cell Reconstitution at 100 Days after T Cell-Replete Hematopoietic Cell Transplantation (HCT) for SCID Is Associated with Later Risk of Death or Need for 2nd Transplant in the 6901 Prospective Study of the Pidtc

Publication ,  Conference
Heimall, J; Logan, BR; Cowan, MJ; Notarangelo, LD; Puck, J; Fleisher, T; Griffith, LM; Kohn, DB; Pulsipher, MA; Shearer, W; Hanson, IC ...
Published in: Biology of Blood and Marrow Transplantation
March 2016

Duke Scholars

Published In

Biology of Blood and Marrow Transplantation

DOI

ISSN

1083-8791

Publication Date

March 2016

Volume

22

Issue

3

Start / End Page

S101 / S102

Publisher

Elsevier BV

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Heimall, J., Logan, B. R., Cowan, M. J., Notarangelo, L. D., Puck, J., Fleisher, T., … Buckley, R. H. (2016). Poor T Cell Reconstitution at 100 Days after T Cell-Replete Hematopoietic Cell Transplantation (HCT) for SCID Is Associated with Later Risk of Death or Need for 2nd Transplant in the 6901 Prospective Study of the Pidtc. In Biology of Blood and Marrow Transplantation (Vol. 22, pp. S101–S102). Elsevier BV. https://doi.org/10.1016/j.bbmt.2015.11.404
Heimall, Jennifer, Brent R. Logan, Morton J. Cowan, Luigi D. Notarangelo, Jennifer Puck, Thomas Fleisher, Linda M. Griffith, et al. “Poor T Cell Reconstitution at 100 Days after T Cell-Replete Hematopoietic Cell Transplantation (HCT) for SCID Is Associated with Later Risk of Death or Need for 2nd Transplant in the 6901 Prospective Study of the Pidtc.” In Biology of Blood and Marrow Transplantation, 22:S101–2. Elsevier BV, 2016. https://doi.org/10.1016/j.bbmt.2015.11.404.
Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Puck J, Fleisher T, et al. Poor T Cell Reconstitution at 100 Days after T Cell-Replete Hematopoietic Cell Transplantation (HCT) for SCID Is Associated with Later Risk of Death or Need for 2nd Transplant in the 6901 Prospective Study of the Pidtc. In: Biology of Blood and Marrow Transplantation. Elsevier BV; 2016. p. S101–2.
Heimall, Jennifer, et al. “Poor T Cell Reconstitution at 100 Days after T Cell-Replete Hematopoietic Cell Transplantation (HCT) for SCID Is Associated with Later Risk of Death or Need for 2nd Transplant in the 6901 Prospective Study of the Pidtc.” Biology of Blood and Marrow Transplantation, vol. 22, no. 3, Elsevier BV, 2016, pp. S101–02. Crossref, doi:10.1016/j.bbmt.2015.11.404.
Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Puck J, Fleisher T, Griffith LM, Kohn DB, Pulsipher MA, Shearer W, Hanson IC, Kapoor N, O’Reilly RJ, Boyer M, Pai S-Y, Parikh S, Goldman F, Burroughs L, Marsh RA, Kletzel M, Thakar M, Connelly JA, Cuvellier G, Loechelt B, Shereck E, Knudsen A, Sullivan K, DeSantes K, Gillio AP, Haddad E, Petrovic A, Quigg TC, Smith AR, Stenger E, Dvorak CC, Buckley RH. Poor T Cell Reconstitution at 100 Days after T Cell-Replete Hematopoietic Cell Transplantation (HCT) for SCID Is Associated with Later Risk of Death or Need for 2nd Transplant in the 6901 Prospective Study of the Pidtc. Biology of Blood and Marrow Transplantation. Elsevier BV; 2016. p. S101–S102.
Journal cover image

Published In

Biology of Blood and Marrow Transplantation

DOI

ISSN

1083-8791

Publication Date

March 2016

Volume

22

Issue

3

Start / End Page

S101 / S102

Publisher

Elsevier BV

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences